We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 6 juli 2018

British Journal of Cancer - Table of Contents alert Volume 119 Issue 1

If you are unable to see the message below, click here to view.
British Journal of Cancer

Volume 119, Issue 1

In this issue
Review Article
Brief Communication
Also new


TGFβ shuts the door on T cells

Tobias Bald & Mark J. Smyth

British Journal of Cancer 2018 119 :1 - 3; June 14, 2018; 10.1038/s41416-018-0122-x


Abstract | Full Text

Review Article

Checkpoint blockade in the treatment of breast cancer: current status and future directions

Lironne Wein, Stephen J Luen, Peter Savas, Roberto Salgado & Sherene Loi

British Journal of Cancer 2018 119 :4 - 11; May 29, 2018; 10.1038/s41416-018-0126-6


Abstract | Full Text


Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial

Tingyan Shi, Rong Jiang, Jinjin Yu, Huijuan Yang, Dongsheng Tu et al.

British Journal of Cancer 2018 119 :12 - 18; June 14, 2018; 10.1038/s41416-018-0036-7


Abstract | Full Text

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study

Ian Chau, Joon Oh Park, Baek-Yeol Ryoo, Chia-Jui Yen, Ronnie Poon et al.

British Journal of Cancer 2018 119 :19 - 26; May 29, 2018; 10.1038/s41416-018-0103-0


Abstract | Full Text

Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial

Alison C. Backen, Andre Lopes, Harpreet Wasan, Daniel H Palmer, Marian Duggan et al.

British Journal of Cancer 2018 119 :27 - 35; June 21, 2018; 10.1038/s41416-018-0132-8


Abstract | Full Text

Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ

Louisa Lisa Lo, Roger Laughlin Milne, Yuyan Liao, Jack Cuzick, Mary Beth Terry et al.

British Journal of Cancer 2018 119 :36 - 39; June 21, 2018; 10.1038/s41416-018-0120-z


Abstract | Full Text

The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores

Ross D Dolan, Stephen T McSorley, James H Park, David G Watt, Campbell S Roxburgh et al.

British Journal of Cancer 2018 119 :40 - 51; May 23, 2018; 10.1038/s41416-018-0095-9


Abstract | Full Text

G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS

Venugopalan Cheriyath, Jaspreet Kaur, Anne Davenport, Ashjan Khalel, Nobel Chowdhury et al.

British Journal of Cancer 2018 119 :52 - 64; June 14, 2018; 10.1038/s41416-018-0137-3


Abstract | Full Text

Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma

Duo Xu, Shun-Qing Liang, Haitang Yang, Ursina Lüthi, Carsten Riether et al.

British Journal of Cancer 2018 119 :65 - 75; June 20, 2018; 10.1038/s41416-018-0145-3


Abstract | Full Text

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

Séverine Guiu, Caroline Mollevi, Céline Charon-Barra, Florence Boissière, Evelyne Crapez et al.

British Journal of Cancer 2018 119 :76 - 79; June 08, 2018; 10.1038/s41416-018-0142-6


Abstract | Full Text

Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma

Chao-Qun Liu, Jing Xu, Zhong-Guo Zhou, Li-Lian Jin, Xing-Juan Yu et al.

British Journal of Cancer 2018 119 :80 - 88; June 20, 2018; 10.1038/s41416-018-0144-4


Abstract | Full Text

Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma

Anna Kaisa Kylmä, Lauri Jouhi, Dyah Listyarifah, Hesham Mohamed, Antti Mäkitie et al.

British Journal of Cancer 2018 119 :89 - 95; June 22, 2018; 10.1038/s41416-018-0143-5


Abstract | Full Text

Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease

Martina Mijuskovic, Edward J. Saunders, Daniel A. Leongamornlert, Sarah Wakerell, Ian Whitmore et al.

British Journal of Cancer 2018 119 :96 - 104; June 19, 2018; 10.1038/s41416-018-0141-7


Abstract | Full Text

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies

Clément Vialatte de Pémille, Giulia Berzero, Mathilde Small, Dimitri Psimaras, Marine Giry et al.

British Journal of Cancer 2018 119 :105 - 113; June 14, 2018; 10.1038/s41416-018-0125-7


Abstract | Full Text

Heterogeneous relationships of squamous and basal cell carcinomas of the skin with smoking: the UK Million Women Study and meta-analysis of prospective studies

Kirstin Pirie, Valerie Beral, Alicia K. Heath, Jane Green, Gillian K. Reeves et al.

British Journal of Cancer 2018 119 :114 - 120; June 14, 2018; 10.1038/s41416-018-0105-y


Abstract | Full Text

Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group

Marloes G. M. Derks, Esther Bastiaannet, Mandy Kiderlen, Denise E. Hilling, Petra G. Boelens et al.

British Journal of Cancer 2018 119 :121 - 129; June 07, 2018; 10.1038/s41416-018-0090-1


Abstract | Full Text

Brief Communication

Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort

Rui Zheng, Mulong Du, Baoguo Zhang, Junyi Xin, Haiyan Chu et al.

British Journal of Cancer 2018 119 :130 - 132; June 06, 2018; 10.1038/s41416-018-0121-y


Abstract | Full Text


Comment on “How the evolution of multicellularity set the stage for cancer”

Pascal Jézéquel & Mario Campone

British Journal of Cancer 2018 119 :133 - 134; May 14, 2018; 10.1038/s41416-018-0091-0


Abstract | Full Text

Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature